CCR5 antagonists: 3-(pyrrolidin-1-yl)propionic acid analogues with potent anti-HIV activity

被引:17
作者
Lynch, CL
Hale, JJ
Budhu, RJ
Gentry, AL
Finke, PE
Caldwell, CG
Mills, SG
MacCoss, M
Shen, DM
Chapman, KT
Malkowitz, L
Springer, MS
Gould, SL
DeMartino, JA
Siciliano, SJ
Cascieri, MA
Carella, A
Carver, G
Karen, H
Schleif, WA
Danzeisen, R
Hazuda, D
Kessler, J
Lineberger, J
Miller, M
Emini, E
机构
[1] Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
[2] Merck Res Labs, Dept Immunol Res, Rahway, NJ 07065 USA
[3] Merck Res Labs, Dept Antiviral Res, W Point, PA 19486 USA
关键词
D O I
10.1021/ol034707c
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
graphic A novel approach to alpha,alpha-disubstituted-beta-amino acids (beta(2,2)-amino acids) was employed in the synthesis of a series of 3-(pyrrolidin-1-yl)-propionic acids possessing high affinity for the CCR5 receptor and potent anti-HIV activity. The rat pharmacokinetics for these new analogues featured higher bioavailabilities and lower rates of clearance as compared to cyclopentane 1.
引用
收藏
页码:2473 / 2475
页数:3
相关论文
共 10 条
  • [1] Abele S, 2000, EUR J ORG CHEM, V2000, P1
  • [2] TETRAMETHYL 1,1,4,4-CYCLOHEXANETETRACARBOXYLATE - PREPARATION AND CONVERSION TO KEY PRECURSORS OF FLUORINATED, STEREOCHEMICALLY DEFINED CYCLOHEXANES
    DAVIS, CR
    SWENSON, DC
    BURTON, DJ
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 1993, 58 (24) : 6843 - 6850
  • [3] FINKE PE, 2002, INFL RES ASS 11 NAT
  • [4] 1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 1: Discovery of the pyrrolidine scaffold and determination of its stereochemical requirements
    Hale, JJ
    Budhu, RJ
    Mills, SG
    MacCoss, M
    Malkowitz, L
    Siciliano, S
    Gould, SL
    DeMartino, JA
    Springer, MS
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (11) : 1437 - 1440
  • [5] Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells
    Hazuda, DJ
    Felock, P
    Witmer, M
    Wolfe, A
    Stillmock, K
    Grobler, JA
    Espeseth, A
    Gabryelski, L
    Schleif, W
    Blau, C
    Miller, MD
    [J]. SCIENCE, 2000, 287 (5453) : 646 - 650
  • [6] KAJIKAWA A, 1975, TETRAHECRON LETT, V16, P4135
  • [7] Preparation and synthetic applications of sterically hindered secondary amines
    Kim, HO
    Carroll, B
    Lee, MS
    [J]. SYNTHETIC COMMUNICATIONS, 1997, 27 (14) : 2505 - 2515
  • [8] 1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists: Modifications of the arylpropylpiperidine side chains
    Lynch, CL
    Willoughby, CA
    Hale, JJ
    Holson, EJ
    Budhu, RJ
    Gentry, AL
    Rosauer, KG
    Caldwell, CG
    Chen, P
    Mills, SG
    MacCoss, M
    Berk, S
    Chen, L
    Chapman, KT
    Malkowitz, L
    Springer, MS
    Gould, SL
    DeMartino, JA
    Siciliano, SJ
    Cascieri, MA
    Carella, A
    Carver, G
    Holmes, K
    Schleif, WA
    Danzeisen, R
    Hazuda, D
    Kessler, J
    Lineberger, J
    Miller, M
    Emini, EA
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (01) : 119 - 123
  • [9] 1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 4: Synthesis of N-1 acidic functionality affording analogues with enhanced antiviral activity against HIV
    Lynch, CL
    Hale, JJ
    Budhu, RJ
    Gentry, AL
    Mills, SG
    Chapman, KT
    MacCoss, M
    Malkowitz, L
    Springer, MS
    Gould, SL
    DeMartino, JA
    Siciliano, SJ
    Cascieri, MA
    Carella, A
    Carver, G
    Holmes, K
    Schleif, WA
    Danzeisen, R
    Hazuda, D
    Kessler, J
    Lineberger, J
    Miller, M
    Emini, EA
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (20) : 3001 - 3004
  • [10] A critical site in the core of the CCR5 chemokine receptor required for binding and infectivity of human immunodeficiency virus type 1
    Siciliano, SJ
    Kuhmann, SE
    Weng, YM
    Madani, N
    Springer, MS
    Lineberger, JE
    Danzeisen, R
    Miller, MD
    Kavanaugh, MP
    DeMartino, JA
    Kabat, D
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (04) : 1905 - 1913